Health Canada drug identification number

DIN 02534622 — KENGREXAL 50 MG

KENGREXAL is a powder for solution of Cangrelor marketed by CHIESI FARMACEUTICI S.P.A.. The full Cangrelor monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02534622
Brand name
KENGREXAL
Active ingredient
Cangrelor
Strength
50 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
CHIESI FARMACEUTICI S.P.A.
Health Canada status
MARKETED
Drug class
P2Y12 platelet inhibitor (antiplatelet agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.